For the right patient with GERD, PPIs remain the medical treatment of choice, and their benefits outweigh the potential risks when used at the lowest effective dose, the ACG says.
Draft recommendations suggest those aged 40-59 at low bleeding but high CVD risk may consider aspirin for prevention, but advise against it in those 60 and older, or for colorectal cancer prevention.